Retinal Vascular Disease Symposium

Related

• 

  Phase III Randomized Clinical Trial Comparing SB15 With Reference Aflibercept in Neovascular Age-Related Macular Degeneration 56-Week Results

  Min Sagong, MD

  Annual Meeting Talks

  2023

• 

  Course of Macular Edema Through 36 Months With Fluocinolone Acetonide Intravitreal Insert for Non-infectious Uveitis Affecting the Posterior Segment

  Seenu M. Hariprasad, MD

  Annual Meeting Talks

  2020

• 

  Additional Visual and Anatomic Outcomes of Intravitreal Aflibercept Injection, 8 mg vs 2 mg: Post Hoc Analysis of the Phase 2 CANDELA Study

  Priya Sharma Vakharia, MD

  Annual Meeting Talks

  2023